Bayer and Johnson & Johnson have successfully defended the safety of their big-selling clotbuster Xarelto in court, but as the case count continues to climb, the companies have agreed to shell out $775 million to wrap them up.
The drugmakers will split the settlement 50-50, Bayer says. The deal will resolve “virtually all” of about 25,000 outstanding cases, which claim Xarelto caused severe and sometimes fatal bleeding episodes. Bayer expects its liability insurance to cover part of the settlement costs.
“Bayer continues to believe these claims are without merit and there is no admission of liability under the agreement,” the company said. “However, this favorable settlement allows the company to avoid the distraction and significant cost of continued litigation.”
The Xarelto Side Effects Included Bleeding Side Effects including:
Uncontrollable internal bleeding
Bleeding from the rectum
Intestinal or abdominal bleeds
Blood in vomit
Prolonged bleeding from cuts or gums
ADDITIONAL SIDE EFFECTS INCLUDE:
Loss of ability to control movement
Numb or tingling muscles
Abnormal liver function
Reduced platelet levels
Difficulty breathing or swallowing
Bladder or bowel dysfunction
Our firm had many of these mass tort cases, once we have a resolution we will let our clients know.